Can early malignant melanoma be differentiated from atypical melanocytic nevi by in vivo techniques?: Part I. Clinical and dermoscopic characteristics.

Rao, B K; Marghoob, A A; Stolz, W; Kopf, A W; Slade, J; Wasti, Q; Schoenbach, S P; De-David, M; Bart, R S

Rao, B K; Marghoob, A A; Stolz, W; Kopf, A W; Slade, J; Wasti, Q; Schoenbach, S P; De-David, M; Bart, R S.

Afiliação

Rao BK; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
Marghoob AA; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
Stolz W; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
Kopf AW; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
Slade J; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
Wasti Q; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
Schoenbach SP; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
De-David M; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the
Bart RS; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine and the Oncology Section, Charles C. Harris Skin and Cancer Pavilion, New York University Medical Center; the New York University Melanoma Cooperative Group, New York, New York1the Department of Dermatology, the

Skin Res Technol ; 3(1): 8-14, 1997 Feb.

Article em En | MEDLINE | ID: mdl-27333167

Palavras-chave

atypical melanocytic nevi; malignant melanoma

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Skin Res Technol Assunto da revista: DERMATOLOGIA Ano de publicação: 1997 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google